Clinical Trial Update: Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating radiotherapy with leuprolide and enzalutamide in high-risk prostate cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Leuprolide (Leuprolide acetate)
• Radiotherapy

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostatic Neoplasms, Pelvic Nodal | Phase 2 | Status: TERMINATED | Results posted: 2021-10-12